These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 15488171

  • 1. RGS2-mediated regulation of Gqalpha.
    Heximer SP.
    Methods Enzymol; 2004; 390():65-82. PubMed ID: 15488171
    [Abstract] [Full Text] [Related]

  • 2. Single-cell imaging of intracellular Ca2+ and phospholipase C activity reveals that RGS 2, 3, and 4 differentially regulate signaling via the Galphaq/11-linked muscarinic M3 receptor.
    Tovey SC, Willars GB.
    Mol Pharmacol; 2004 Dec; 66(6):1453-64. PubMed ID: 15383626
    [Abstract] [Full Text] [Related]

  • 3. Lack of receptor-selective effects of either RGS2, RGS3 or RGS4 on muscarinic M3- and gonadotropin-releasing hormone receptor-mediated signalling through G alpha q/11.
    Karakoula A, Tovey SC, Brighton PJ, Willars GB.
    Eur J Pharmacol; 2008 Jun 10; 587(1-3):16-24. PubMed ID: 18457830
    [Abstract] [Full Text] [Related]

  • 4. Palmitoylation and its effect on the GTPase-activating activity and conformation of RGS2.
    Ni J, Qu L, Yang H, Wang M, Huang Y.
    Int J Biochem Cell Biol; 2006 Jun 10; 38(12):2209-18. PubMed ID: 16945566
    [Abstract] [Full Text] [Related]

  • 5. A novel regulator of G protein signalling in yeast, Rgs2, downregulates glucose-activation of the cAMP pathway through direct inhibition of Gpa2.
    Versele M, de Winde JH, Thevelein JM.
    EMBO J; 1999 Oct 15; 18(20):5577-91. PubMed ID: 10523302
    [Abstract] [Full Text] [Related]

  • 6. The RGS2 gene product from a candidate hypertension allele shows decreased plasma membrane association and inhibition of Gq.
    Gu S, Tirgari S, Heximer SP.
    Mol Pharmacol; 2008 Apr 15; 73(4):1037-43. PubMed ID: 18230714
    [Abstract] [Full Text] [Related]

  • 7. Application of RGS box proteins to evaluate G-protein selectivity in receptor-promoted signaling.
    Hains MD, Siderovski DP, Harden TK.
    Methods Enzymol; 2004 Apr 15; 389():71-88. PubMed ID: 15313560
    [Abstract] [Full Text] [Related]

  • 8. Allosteric regulation of GAP activity by phospholipids in regulators of G-protein signaling.
    Tu Y, Wilkie TM.
    Methods Enzymol; 2004 Apr 15; 389():89-105. PubMed ID: 15313561
    [Abstract] [Full Text] [Related]

  • 9. RGS proteins: Swiss army knives in seven-transmembrane domain receptor signaling networks.
    Heximer SP, Blumer KJ.
    Sci STKE; 2007 Jan 23; 2007(370):pe2. PubMed ID: 17244887
    [Abstract] [Full Text] [Related]

  • 10. Tuning cardiomyocyte Gq signaling with RGS2.
    Muslin AJ.
    J Mol Cell Cardiol; 2006 Jul 23; 41(1):14-6. PubMed ID: 16730746
    [No Abstract] [Full Text] [Related]

  • 11. Modeled structure of the whole regulator G-protein signaling-2.
    Tikhonova IG, Boulègue C, Langer I, Fourmy D.
    Biochem Biophys Res Commun; 2006 Mar 17; 341(3):715-20. PubMed ID: 16434022
    [Abstract] [Full Text] [Related]

  • 12. Alternative splicing of RGS8 gene determines inhibitory function of receptor type-specific Gq signaling.
    Saitoh O, Murata Y, Odagiri M, Itoh M, Itoh H, Misaka T, Kubo Y.
    Proc Natl Acad Sci U S A; 2002 Jul 23; 99(15):10138-43. PubMed ID: 12110731
    [Abstract] [Full Text] [Related]

  • 13. G-protein signaling through tubby proteins.
    Santagata S, Boggon TJ, Baird CL, Gomez CA, Zhao J, Shan WS, Myszka DG, Shapiro L.
    Science; 2001 Jun 15; 292(5524):2041-50. PubMed ID: 11375483
    [Abstract] [Full Text] [Related]

  • 14. Regulation of cardiomyocyte signaling by RGS proteins: differential selectivity towards G proteins and susceptibility to regulation.
    Hao J, Michalek C, Zhang W, Zhu M, Xu X, Mende U.
    J Mol Cell Cardiol; 2006 Jul 15; 41(1):51-61. PubMed ID: 16756988
    [Abstract] [Full Text] [Related]

  • 15. Angiotensin II-evoked enhanced expression of RGS2 attenuates Gi-mediated adenylyl cyclase signaling in A10 cells.
    Li Y, Hashim S, Anand-Srivastava MB.
    Cardiovasc Res; 2005 Jun 01; 66(3):503-11. PubMed ID: 15914115
    [Abstract] [Full Text] [Related]

  • 16. Potent and selective inhibition of angiotensin AT1 receptor signaling by RGS2: roles of its N-terminal domain.
    Matsuzaki N, Nishiyama M, Song D, Moroi K, Kimura S.
    Cell Signal; 2011 Jun 01; 23(6):1041-9. PubMed ID: 21291998
    [Abstract] [Full Text] [Related]

  • 17. N-terminal residues control proteasomal degradation of RGS2, RGS4, and RGS5 in human embryonic kidney 293 cells.
    Bodenstein J, Sunahara RK, Neubig RR.
    Mol Pharmacol; 2007 Apr 01; 71(4):1040-50. PubMed ID: 17220356
    [Abstract] [Full Text] [Related]

  • 18. Evidence for a direct and functional interaction between the regulators of G protein signaling-2 and phosphorylated C terminus of cholecystokinin-2 receptor.
    Langer I, Tikhonova IG, Boulègue C, Estève JP, Vatinel S, Ferrand A, Moroder L, Robberecht P, Fourmy D.
    Mol Pharmacol; 2009 Mar 01; 75(3):502-13. PubMed ID: 19064631
    [Abstract] [Full Text] [Related]

  • 19. Fluorescence-based assays for RGS box function.
    Willard FS, Kimple RJ, Kimple AJ, Johnston CA, Siderovski DP.
    Methods Enzymol; 2004 Mar 01; 389():56-71. PubMed ID: 15313559
    [Abstract] [Full Text] [Related]

  • 20. Regulator of G-protein signaling 2 (RGS2) inhibits androgen-independent activation of androgen receptor in prostate cancer cells.
    Cao X, Qin J, Xie Y, Khan O, Dowd F, Scofield M, Lin MF, Tu Y.
    Oncogene; 2006 Jun 22; 25(26):3719-34. PubMed ID: 16449965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.